BioSpace News Archive

Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that an Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) trial evaluating VIR-7831 (GSK4182136) as monotherapy for the early treatment of COVID-19 in adults at high risk of hospitalization be stopped for enrollment due to evidence of profound efficacy

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel recombinant proteins in the treatments for neurological and kidney diseases, today announced it will be presenting a plenary talk at the American Heart Association 2021 International Stroke Conference titled “Safety and Tolerability of Recombinant Human Tissue Kallikrein (DM199) In Acute Ischemic Stroke: A Randomized Clinical Trial”.

Health Catalyst, Inc. (“Health Catalyst,”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of the new Healthcare.AI

Signatera used to identify muscle-invasive urothelial carcinoma patients who are MRD-positive after surgery, for enrollment in IMvigor011 study evaluating adjuvant immunotherapy with atezolizumab

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill™ Device, an expansion of the IMPEDE family of biodegradable peripheral vascular embolization plugs.

Cybin to Present at the Stifel GMP Healthcare Conference – Healthcare Psychedelics: Addressing the Global Mental Health Crisis

To address the growing administrative burden on clinicians and the inefficiencies and added costs of unconnected systems, Michigan Medicine will partner with 3M Health Information Systems to implement a full portfolio of 3M technology across its health care system.

The New Jersey Hospital Association unveiled a new partnership with other statewide organizations to highlight tailored COVID-19 vaccination information to New Jersey constituencies as the state prepares to expand vaccine eligibility to more groups.

InsiteOne LLC, a provider of offsite enterprise imaging archiving solutions, announced a return to the market with a comprehensive set of state of the art private and public cloud offerings and supplementary services.

AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), and etesevimab 1400 mg (LY-CoV16) together reduced COVID-19-related hospitalization